Clinical Trials Sponsored by Karyopharm Therapeutics Inc
Total 2944 results
-
Karyopharm Therapeutics IncNot yet recruitingMyelofibrosis | Moderate Thrombocytopenia
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Karyopharm Therapeutics IncCompletedMultiple MyelomaUnited States, Belgium, Austria, France, Germany, Greece
-
Karyopharm Therapeutics IncCompletedCervical Carcinoma | Endometrial Carcinoma | Ovarian CarcinomaDenmark, Belgium
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Karyopharm Therapeutics IncTerminatedRichter's TransformationUnited States, Germany, United Kingdom, Spain, Poland
-
Karyopharm Therapeutics IncWithdrawn
-
Karyopharm Therapeutics IncWithdrawn
-
Karyopharm Therapeutics IncWithdrawnDiabetic Foot UlcersNew Zealand
-
Karyopharm Therapeutics IncTerminated
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States, Korea, Republic of, Spain, France, Italy, Israel, Canada, Romania
-
Karyopharm Therapeutics IncRecruitingOther Solid Tumors | Colorectal Cancer (CRC) | Non-Small Cell Lung Carcinoma (NSCLC)Israel
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
Karyopharm Therapeutics IncTerminated
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Karyopharm Therapeutics IncCompletedSolid TumorUnited States, Denmark, Canada
-
Karyopharm Therapeutics IncTerminated
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Karyopharm Therapeutics IncTerminatedSolid Tumors | NHLUnited States, Canada
-
Karyopharm Therapeutics IncRecruiting
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
Karyopharm Therapeutics IncCompletedSarcomaUnited States, Canada
-
Karyopharm Therapeutics IncTerminatedGlioblastoma MultiformeUnited States, Canada
-
Karyopharm Therapeutics IncTerminatedSquamous Cell CarcinomaUnited States, Canada
-
Karyopharm Therapeutics IncWithdrawn
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia (AML)Canada, United States, Israel, Netherlands, Denmark, Spain, France, Italy, United Kingdom, Germany, Poland
-
Karyopharm Therapeutics IncWithdrawnMultiple MyelomaUnited States
-
Karyopharm Therapeutics IncTerminatedGlioma | GlioblastomaUnited States, Denmark, Netherlands
-
Karyopharm Therapeutics IncCompletedDedifferentiated LiposarcomaUnited States, United Kingdom, Israel, France, Canada, Spain, Belgium, Sweden, Germany, Italy
-
Karyopharm Therapeutics IncCompletedCoronavirus InfectionUnited States, Spain, France, United Kingdom, Israel, Austria
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Loyola UniversityKaryopharm Therapeutics IncRecruitingOvarian CancerUnited States
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
University of MiamiKaryopharm Therapeutics IncRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
University of UtahKaryopharm Therapeutics IncActive, not recruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
Sheba Medical CenterKaryopharm Therapeutics IncUnknown
-
Gabrail Cancer Center ResearchKaryopharm Therapeutics IncCompletedCarcinoma, NeuroendocrineUnited States
-
University of Colorado, DenverKaryopharm Therapeutics IncRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
University Health Network, TorontoKaryopharm Therapeutics IncCompleted
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
The Lymphoma Academic Research OrganisationKaryopharm Therapeutics IncCompleted
-
Matthew InghamTakeda; Karyopharm Therapeutics IncWithdrawnSarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom